PT1514871E - Diespiro 1,2,4-trioxolanos contra a malária - Google Patents
Diespiro 1,2,4-trioxolanos contra a malária Download PDFInfo
- Publication number
- PT1514871E PT1514871E PT42548214T PT04254821T PT1514871E PT 1514871 E PT1514871 E PT 1514871E PT 42548214 T PT42548214 T PT 42548214T PT 04254821 T PT04254821 T PT 04254821T PT 1514871 E PT1514871 E PT 1514871E
- Authority
- PT
- Portugal
- Prior art keywords
- dispiro
- trioxolane antimalarials
- trioxolane
- antimalarials
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
- C07D323/02—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/642,721 US6825230B2 (en) | 2002-06-21 | 2003-08-18 | Spiro and dispiro 1,2,4-trixolane antimalarials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1514871E true PT1514871E (pt) | 2016-02-08 |
Family
ID=31888549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT42548214T PT1514871E (pt) | 2003-08-18 | 2004-08-11 | Diespiro 1,2,4-trioxolanos contra a malária |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6825230B2 (pt) |
| EP (2) | EP2599779A1 (pt) |
| JP (1) | JP2005060396A (pt) |
| KR (1) | KR20050020946A (pt) |
| CN (1) | CN1626530A (pt) |
| AU (1) | AU2004203864B2 (pt) |
| CA (1) | CA2478146C (pt) |
| CY (1) | CY1117133T1 (pt) |
| DK (1) | DK1514871T3 (pt) |
| ES (1) | ES2560080T3 (pt) |
| HU (1) | HUE028313T2 (pt) |
| MX (1) | MXPA04008022A (pt) |
| PL (2) | PL1514871T3 (pt) |
| PT (1) | PT1514871E (pt) |
| SG (2) | SG139752A1 (pt) |
| SI (1) | SI1514871T1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7371778B2 (en) * | 2002-06-21 | 2008-05-13 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US6825230B2 (en) * | 2002-06-21 | 2004-11-30 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trixolane antimalarials |
| US20080125441A1 (en) * | 2002-06-21 | 2008-05-29 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US20080275112A1 (en) * | 2004-07-23 | 2008-11-06 | Schreiner Peter R | Invention Concerning Aminoadamantane Compounds |
| GB0421911D0 (en) * | 2004-10-01 | 2004-11-03 | Univ Cambridge Tech | Methods and means |
| US8067620B2 (en) * | 2005-05-04 | 2011-11-29 | Medicines For Malaria Venture Mmv | Dispiro 1,2,4-trioxolane antimalarials |
| HUE033191T2 (en) * | 2005-05-18 | 2017-11-28 | Sun Pharmaceutical Ind Ltd | Stable dosage forms of spiro and dispiro-1,2,4-trioxolane anti-malarial agents |
| CN101472582A (zh) * | 2006-05-17 | 2009-07-01 | 兰贝克赛实验室有限公司 | 联用合成青蒿素衍生物和双喹啉衍生物的抗疟疗法 |
| AP2440A (en) * | 2006-05-24 | 2012-08-31 | Ranbaxy Lab Ltd | A process for the preparation of dispiro 1,2,4-trioxolane antimalarials 'OZ277' |
| FR2924343A1 (fr) * | 2007-12-04 | 2009-06-05 | Palumed Sa | Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique. |
| JP5587776B2 (ja) * | 2008-07-01 | 2014-09-10 | 国立大学法人 岡山大学 | 新規抗住血吸虫剤 |
| BRPI1011347A2 (pt) | 2009-04-17 | 2015-08-25 | Ranbaxy Lab Ltd | Cis-adamantano-2-spiro-3'-8'-[[[(2'-amino-2'metil propil) amino]carbonil]metil]-1',2',4'-trioxaspiro[4.5]decano, processo para sua preparação e seu uso. |
| EA201490233A8 (ru) | 2011-07-14 | 2015-01-30 | Ранбакси Лабораториз Лимитед | Стабильные лекарственные формы артеролана и пиперахина |
| JP6889433B2 (ja) | 2014-02-14 | 2021-06-18 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | 薬剤の選択的送達のためのプロドラッグとしての環状ペルオキシド |
| WO2019005977A1 (en) | 2017-06-27 | 2019-01-03 | The Regents Of The University Of California | TRIOXOLANE AGENTS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6486199B1 (en) * | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US6825230B2 (en) * | 2002-06-21 | 2004-11-30 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trixolane antimalarials |
-
2003
- 2003-08-18 US US10/642,721 patent/US6825230B2/en not_active Expired - Lifetime
-
2004
- 2004-08-03 SG SG200800498-8A patent/SG139752A1/en unknown
- 2004-08-03 SG SG200404498A patent/SG109559A1/en unknown
- 2004-08-11 DK DK04254821.4T patent/DK1514871T3/en active
- 2004-08-11 EP EP12153804.5A patent/EP2599779A1/en not_active Withdrawn
- 2004-08-11 PL PL04254821T patent/PL1514871T3/pl unknown
- 2004-08-11 ES ES04254821.4T patent/ES2560080T3/es active Active
- 2004-08-11 PT PT42548214T patent/PT1514871E/pt unknown
- 2004-08-11 SI SI200432293T patent/SI1514871T1/sl unknown
- 2004-08-11 HU HUE04254821A patent/HUE028313T2/en unknown
- 2004-08-11 EP EP04254821.4A patent/EP1514871B1/en active Active
- 2004-08-12 AU AU2004203864A patent/AU2004203864B2/en not_active Ceased
- 2004-08-16 JP JP2004236304A patent/JP2005060396A/ja active Pending
- 2004-08-17 KR KR1020040064608A patent/KR20050020946A/ko not_active Application Discontinuation
- 2004-08-17 MX MXPA04008022A patent/MXPA04008022A/es active IP Right Grant
- 2004-08-17 CA CA002478146A patent/CA2478146C/en active Active
- 2004-08-18 PL PL369644A patent/PL227294B1/pl unknown
- 2004-08-18 CN CNA2004100578183A patent/CN1626530A/zh active Pending
-
2016
- 2016-01-18 CY CY20161100047T patent/CY1117133T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1514871B1 (en) | 2015-10-21 |
| SI1514871T1 (sl) | 2016-02-29 |
| HUE028313T2 (en) | 2016-12-28 |
| CA2478146A1 (en) | 2006-02-17 |
| US20040039008A1 (en) | 2004-02-26 |
| PL369644A1 (en) | 2005-02-21 |
| ES2560080T3 (es) | 2016-02-17 |
| CY1117133T1 (el) | 2017-04-05 |
| AU2004203864B9 (en) | 2005-03-10 |
| PL1514871T3 (pl) | 2016-05-31 |
| AU2004203864A1 (en) | 2005-03-10 |
| SG109559A1 (en) | 2005-03-30 |
| EP2599779A1 (en) | 2013-06-05 |
| PL227294B1 (pl) | 2017-11-30 |
| EP1514871A1 (en) | 2005-03-16 |
| DK1514871T3 (en) | 2016-01-25 |
| SG139752A1 (en) | 2008-02-29 |
| KR20050020946A (ko) | 2005-03-04 |
| MXPA04008022A (es) | 2005-06-08 |
| CN1626530A (zh) | 2005-06-15 |
| US6825230B2 (en) | 2004-11-30 |
| CA2478146C (en) | 2009-02-03 |
| AU2004203864B2 (en) | 2007-06-07 |
| JP2005060396A (ja) | 2005-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1090368A1 (en) | 2,3,6-trisubstituted-4-pyrimidone derivatives | |
| EG25273A (en) | Substituted dihydroquinazolines. | |
| MX267068B (es) | Derivados simetricos de triazina. | |
| ZA200606974B (en) | Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives | |
| HK1086012A1 (en) | 8-substitued-6,7,8,9-tetrahydropyrimidoÄ1,2-aÜ pyrimidin-4-one derivatives | |
| HK1088893A1 (en) | Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimidoÄ1,2-aÜ pyrimidin-4-one derivatives | |
| ZA200506744B (en) | PyrazoloÄ1,5-AÜpyrimidine derivatives | |
| EP1830858A4 (en) | 3,6-BICYCLOLIDE | |
| PT1514871E (pt) | Diespiro 1,2,4-trioxolanos contra a malária | |
| IL173884A0 (en) | Cycloalkylaminoacid compounds, processes for making and uses thereof | |
| AP2006003588A0 (en) | Compounds artemisinin. | |
| EP1723125A4 (en) | 1,2,4-benzotriazine-1,4-dioxides | |
| GB0425572D0 (en) | 1,7-Naphthyridines | |
| EP1711189A4 (en) | AZALIDE DERIVATIVES 8A 6,11-3C-BICYCLIC | |
| LU91022B1 (en) | Sektionaltor. | |
| ZA200702193B (en) | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds | |
| GB0315201D0 (en) | Substituted organopolysiloxanes, methods for the production and use thereof | |
| GB0316852D0 (en) | Compounds, inks and processes | |
| GB0316854D0 (en) | Compounds,inks and processes | |
| TJ391B (en) | Medicinal-preventive biopreparation subtilben. | |
| GB0320813D0 (en) | W.R.M et al | |
| GB0316855D0 (en) | Inks, compounds and processes | |
| GB0317414D0 (en) | Compounds, inks and processes | |
| GB0316358D0 (en) | New uses | |
| GB0315782D0 (en) | Uses |